Bacterial infections by antibiotic-resistant Staphylococcus aureus strains are among the most common postoperative complications in surgical hernia repair with synthetic mesh. Surface coating of medical devices/ implants using antibacterial peptides and enzymes has recently emerged as a potentially effective method for preventing infections. The objective of this study was to evaluate the in vitro antimicrobial activity of hernia repair meshes coated by the antimicrobial enzyme lysostaphin at different initial concentrations. Lysostaphin was adsorbed on pieces of polypropylene (Ultrapro) mesh with binding yields of ϳ10 to 40% at different coating concentrations of between 10 and 500 g/ml. Leaching of enzyme from the surface of all the samples was studied in 2% (wt/vol) bovine serum albumin in phosphate-buffered saline buffer at 37°C, and it was found that less than 3% of adsorbed enzyme desorbed from the surface after 24 h of incubation. Studies of antibacterial activity against a cell suspension of S. aureus were performed using turbidity assay and demonstrated that the small amount of enzyme leaching from the mesh surface contributes to the lytic activity of the lysostaphincoated samples. Colony counting data from the broth count (model for bacteria in wound fluid) and wash count (model for colonized bacteria) for the enzyme-coated samples showed significantly decreased numbers of CFU compared to uncoated samples (P < 0.05). A pilot in vivo study showed a dose-dependent efficacy of lysostaphincoated meshes in a rat model of S. aureus infection. The antimicrobial activity of the lysostaphin-coated meshes suggests that such enzyme-leaching surfaces could be efficient at actively resisting initial bacterial adhesion and preventing subsequent colonization of hernia repair meshes.
The development of an incisional hernia is a common complication after abdominal surgery, which results in 90,000 ventral hernia repair surgeries per year in the United States (25) . The implantation of a prosthetic mesh is a well-established procedure for reconstructing or reinforcing the abdominal wall and has been shown to decrease the rate of hernia recurrence (7, 18, 24) . However, one of the most common problems associated with the use of prosthetic meshes is bacterial infection. The incidence rate for mesh-related infection has been reported to vary between 1% and 18% in different clinical studies (9, 16, 17) .
Staphylococcus aureus is a prevalent microorganism of skin flora; as a consequence, it is responsible for over 90% of surgical site infections as well as mesh related infections (2, 6, 10) . Mesh infection is associated with significant morbidity and is increased considerably in patients with diabetes, immunosuppression, and obesity. Surgical site and implant contamination usually happens at the time of surgery and in the early postoperative period. Current conventional infection-prevention therapies have not been successful in reducing the rate of surgical site infection (8, 26) . Furthermore, operative technique refinements have led to little improvement in the rate of mesh infection (10) . Development of a number of multidrugresistant strains has further complicated the matter, as a study of mesh-related infections following incisional herniorrhaphy demonstrated the prevalence of methicillin-resistant S. aureus (MRSA) in 63% of the cases (9) .
Bacterial adhesion to implanted biomaterial surfaces and proliferation are key steps in the pathogenesis of infection (13, 29, 31) . Multiple experimental and clinical studies have been focusing on the use of different antimicrobial agents immobilized on the surface or released from the bulk of an implant (11) . Increasingly, attention is being paid to surface coatings on implants that contain active compounds that may kill either directly on contact or via leaching over time. Naturally occurring antimicrobial peptides and enzymes have recently attracted much attention because of their high activity, broad antimicrobial spectrum, and low rate of antimicrobial resistance. Balaban et al. found that adsorption of an antibacterial peptide, dermaseptin, to Dacron vascular grafts resulted in increased resistance to bacterial colonization and demonstrated its in vivo efficacy in a rat model (4). Shah et al. demonstrated significant antimicrobial activity against S. aureus for intravenous catheters coated by physically adsorbed lysostaphin and observed high efficacy in vitro (28) .
Lysostaphin is unique in that it possesses extremely high activity against a variety of staphylococcal strains, including MRSA strains. On the basis of literature data, lysostaphin has a reported MIC 90 of 0.001 to 0.064 g/ml (23) . This is comparatively much lower than MIC 90 s for most broad-spectrum antibiotics and drugs that are antimicrobial against S. aureus. For comparison, the MIC 90 for vancomycin, which is currently recommended for treatment of methicillin-resistant S. aureus infections, is 2 g/ml (3). Lysostaphin could therefore be superior to other antibacterial agents in hernia repair-related infections, given that up to 90% of mesh-related infections are caused by S. aureus. Here, we evaluate the in vitro antimicrobial susceptibility of S. aureus to lysostaphin-coated hernia repair polymer meshes and study the effect of enzyme coating concentration on antimicrobial activity.
MATERIALS AND METHODS
Staphylococcus aureus (ATCC 32370) was purchased from the American Type Culture Collection (Manassas, VA). Lysostaphin (25 kDa; LSPN-50) isolated from Staphylococcus staphylolyticus was bought from Ambi Products LLC (Lawrence, NY). Bovine serum albumin (BSA) was bought from Calbiochem (San Diego, CA). Ultrapro lightweight polypropylene mesh with Monocryl weave was from Ethicon Inc., Johnson and Johnson (Langhorne, PA), and Parietex composite mesh (polyester mesh with resorbable film) from Covidien (Mansfield, MA) was donated by the Carolinas Medical Center (Charlotte, NC). Alexa Fluor 594 carboxylic acid, succinimidyl ester, dyes used for fluorescent labeling were purchased from Invitrogen, Molecular Probes (Carlsbad, CA). Microsep centrifugal devices with a modified polyethersulfone membrane (low protein binding; molecular weight cutoff [MWCO], 3,000), used for enzyme purification, were purchased from Pall Life Sciences (Ann Arbor, MI). All other reagents were purchased from Fisher Scientific (Pittsburgh, PA) and used without further purification unless otherwise specified. Type 1 clear borosilicate glass vials (25 ml) with attached screw caps were bought from VWR (West Chester, PA).
Fluorescent labeling of lysostaphin. Alexa Fluor 594 dye was used for fluorescent labeling of lysostaphin due to its enhanced resistance to photobleaching (5) . Fluorescent labeling is considered to be an acceptable method for monitoring protein concentration, which is assumed to be proportional to the fluorescent signal (30) . Labeling of lysostaphin by Alexa Fluor 594 was performed according to the manufacturer's instructions. Approximately 5 g of Alexa Fluor 594 (ε, 73,000) was dissolved in 500 l of dimethylformamide, and 100 l of this solution was added to 2 ml of a 1-mg/ml solution of lysostaphin in 10 mM phosphatebuffered saline (PBS) buffer (10 mM phosphate, 140 mM NaCl, 3 mM KCl). The enzyme was incubated with dye at 30°C for 2 h and then diluted 2-fold in 10 mM PBS buffer and centrifuged at 3,500 ϫ g for 1 h using a Microsep membrane centrifugal device (MWCO, 3,000) to remove any unbound dye, followed by resuspension of the concentrated labeled enzyme in PBS buffer.
Measurement of specific surface area of mesh samples. The specific surface area determined for one of the pieces by Brunauer-Emmett-Teller (BET) analysis of N 2 adsorption at 77 K in a Micromeritics ASAP 2020 analyzer (Micromeritics Instrument Corporation, Norcross, GA) was found to be 5.5 m 2 /g. Prior to N 2 adsorption, the mesh sample was degassed overnight at 80°C. The surface area for each of the mesh pieces used in the following experiments was calculated on the basis of the weight of the piece. The average weight of a 1-by 1-cm Ultrapro mesh piece was 6.9 Ϯ 1.0 mg.
Preparation of lysostaphin-coated meshes. Lightweight polypropylene mesh with Monocryl weave (Ultrapro; Ethicon Inc.) was cut into ϳ1-by 1-cm pieces in a laminar-flow hood under sterile conditions prior to physical adsorption of enzyme. Initial enzyme concentrations of 0.01, 0.025, 0.05, 0.1, 0.25, and 0.5 mg/ml in PBS buffer were prepared from a 1-mg/ml stock solution of Alexa Fluor 594-labeled lysostaphin. The initial fluorescence intensities of the enzyme sample solutions (1 ml) were measured in a 12-well plate (Nunc Inc.) using a microplate reader (excitation wavelength, 594 nm; emission wavelength, 625 nm), and then the samples were added to 25-ml sterile glass vials. Using a pair of sterile tweezers, mesh pieces were gently placed into each of the vials containing the enzyme solutions and incubated overnight at room temperature with gentle shaking (100 rpm). The enzyme solution over the mesh was then collected and stored for fluorescence measurements, and the mesh was gently washed 2 times with 1 ml of PBS buffer. The wash solution was also collected and used in determination of enzyme binding yield. In order to remove any loosely adsorbed enzyme, 1 ml of 0.1% (vol/vol) Tween 20 (a nonionic surfactant) solution was then added to each of the glass vials, followed by incubation for 3 h. This surfactant solution was also collected and used in the determination of the amount of desorbed enzyme, and the mesh samples were then washed with a 25-ml amount of PBS buffer. The concentration of unbound enzyme in each of the supernatants and wash solutions was determined from fluorescence measurements. Initial enzyme solutions with known concentrations were used as the standards. The concentration of the unbound/desorbed enzyme at each step was then calculated and subtracted from the initial concentration of enzyme present in the initial solution. The difference corresponded to the bound enzyme concentration on the mesh. Adsorption experiments were reproduced in triplicate. Note that unlabeled lysostaphin was used in all other experiments except binding efficiency studies.
Leaching studies. Leaching of nonspecifically bound lysostaphin from the surface can occur both in vitro and in vivo. To model in vivo conditions, enzyme leaching was studied for lysostaphin-coated meshes in the presence of BSA. The samples were incubated with 1 ml of 2% (wt/vol) BSA solution in PBS buffer for 24 h at 37°C. Measurements of fluorescence lacked sensitivity to determine the concentration of leached enzyme in the samples. Enzyme concentrations were estimated from the enzyme activity using a turbidity assay. For kinetic measurements, 0.1-ml aliquots from each of the samples were taken at different time points (5, 15 , and 24 h) and added to a 96-well plate. Lysostaphin solutions with known enzyme concentrations of 0.0122 to 25 g/ml were used as standards for each of the different time points. A 100-l cell suspension of S. aureus in PBS buffer with an optical density at 600 nm (OD 600 ) of 0.3 (1-cm light path) was then added to each of the different wells, and the rate of bacterial lysis was monitored continuously for 4 h at 37°C. Enzymatic activity for standards and unknown samples was measured simultaneously in the same microplate. The initial rate of the reaction for each of the standards and unknowns was calculated from the linearized slopes. The standard curve was obtained by plotting the initial rate against the enzyme concentration. From the standard curve, the unknown enzyme concentrations were determined and the amount of leached enzyme for each of the samples was plotted as a function of time. All kinetic experiments were reproduced in triplicate.
Turbidimetric assay. A cell suspension of S. aureus was prepared by inoculating 10 ml of 30% (wt/vol) tryptic soy with 100 l of S. aureus culture prepared according to ATCC instructions. The procedure used was similar to the one employed by Schindler and Schuhardt (27) . The cells were incubated at 37°C for 18 to 24 h under gentle shaking to grow to a mid-log phase. The cells were then pelleted at 3,000 ϫ g for 10 min and washed twice with 10 mM PBS. The cells were then resuspended in PBS to prepare a bacterial suspension with an OD 600 of 0.55 (1-cm light path). One milliliter of the suspension containing ϳ10
7 CFU was added to 25-ml glass vials containing the mesh samples. The samples were incubated with the suspension at 37°C under continuous shaking, and the rate of bacterial lysis was monitored for 5 h by taking 0.2-ml aliquots and measuring the OD 600 in a 96-well plate at different time intervals. Enzyme activity was expressed in units where 1 unit of lysostaphin activity is defined as a decrease of 0.01 absorbance unit at 600 nm, according to the manufacturer's specifications. The vials containing the cell suspension were continuously shaken in order to maintain contact with the meshes. All kinetic experiments were reproduced in triplicate.
Fractional analysis of enzyme activity in leached samples. Fractional analysis of enzyme activity was done to determine whether the antibacterial activity of the lysostaphin-coated meshes comes primarily from immobilized or leached enzyme. A set of mesh samples with the same initial coating concentrations was prepared in duplicate using the procedure described above. All the samples were incubated in 25-ml glass vials containing 0.5 ml of 2% (wt/vol) BSA solution in PBS buffer for 24 h at 37°C. From one set of the samples, the meshes were removed at different time intervals (1, 4 , and 24 h), and a corresponding set containing mesh samples of identical coating concentrations was left intact. A cell suspension of S. aureus was grown to a mid-log phase by a procedure similar to the procedure described above, centrifuged at 3,000 ϫ g for 10 min, washed twice with 10 mM PBS, and resuspended in PBS to a final OD 600 of ϳ0.9. A total of 0.5 ml of this cell suspension was added to the 25-ml glass vials containing each set of the samples, and the final OD of this mixture measured was 0.55 at 600 nm. The samples were incubated with the cell suspension at 37°C under continuous shaking, and the rate of bacterial lysis was monitored for 2 h by taking 0.2-ml aliquots from the reaction mixture and measuring the OD 600 in a 96-well plate at different time intervals. This procedure was done for identical sets of the samples at the different time intervals to compare the enzyme activity of the leached sample against the total activity of the mesh sample incubated in BSA.
Colony counting. The sample meshes were placed in sterile glass vials and challenged with an inoculum of 1 ml of S. aureus suspension in tryptic soy broth containing 6 ϫ 10 7 CFU for 24 h at 37°C. After the incubation, the mesh pieces were retrieved and the broth supernatant was collected for subsequent analysis. Each mesh piece was then washed once vigorously with 1 ml of PBS buffer using a pipette, followed by vortex washing for 5 min, and collected for subsequent colony-counting analysis. Serial dilutions and spot plating were then performed for the broth supernatant (broth count) and the pooled wash (wash count) on agar nutrient plates. The wash count was used to dislodge and quantify the loosely attached bacteria. Bacterial counts were quantified as the number of CFU per ml. All counts were performed in triplicates, and results were calculated as mean log reduction Ϯ standard deviation (SD).
Polyester mesh. Lysostaphin-coated polyester mesh was characterized using a similar set of experiments. All experimental procedures were the same as in the case of the polypropylene mesh; however, all studies were performed for only one lysostaphin coating concentration: 100 g/ml (sample L-100P). The same coating concentration was further used for the polyester mesh in the in vivo study.
In vivo rat model. A total of 40 male Lewis rats (weight, 225 to 275 g; Charles River Laboratories, Raleigh, NC) were used. All animal experiments were approved by the institutional Animal Care and Use Committee (Carolinas Medical Center) and performed in accordance with NIH guidelines. Rats were randomly assigned to 1 of the 10 groups (n ϭ 4 each group), as follows. Groups A to F had polypropylene mesh implanted as an onlay to the anterior abdominal wall fascia. Group A received mesh with no lysostaphin and no S. aureus inoculum. Group B received no lysostaphin and an S. aureus inoculum of 5 ϫ 10 5 CFU. Group C received mesh-bound lysostaphin (initial coating concentration, 50 g/ml) and no S. aureus inoculum. Group D received mesh-bound lysostaphin (initial coating concentration, 50 g/ml) and an S. aureus inoculum of 5 ϫ 10 5 CFU. Group E received mesh-bound lysostaphin (initial coating concentration, 100 g/ml) and no S. aureus inoculum. Group F received mesh-bound lysostaphin (initial coating concentration, 100 g/ml) and an S. aureus inoculum of 5 ϫ 10 5 CFU. Groups G to J had polyester mesh implanted as an onlay to the anterior abdominal wall fascia. Group G received mesh with no lysostaphin and no S. aureus inoculum. Group H received no lysostaphin and an S. aureus inoculum of 5 ϫ 10 5 CFU. Group I received mesh-bound lysostaphin (initial coating concentration, 100 g/ml) and no S. aureus inoculum. Group J received mesh-bound lysostaphin (initial coating concentration, 100 g/ml) and an S. aureus inoculum of 5 ϫ 10 5 CFU. Surgical procedures. Surgical anesthesia was induced and maintained with inhaled isoflurane. The abdominal wall was shaved, prepared first with povidoneiodine (Betadine) and then 70% (vol/vol) isopropyl alcohol and draped in a sterile fashion. A 1-cm midline vertical incision was made through the dermis, and a subcutaneous pocket was then created bilaterally over the anterior abdominal fascia. A 3-cm by 3-cm square piece of sterile polypropylene mesh was placed on the fascia and secured with eight stitches of 4-0 Prolene suture (Ethicon Inc.). For groups assigned to receive the bacterial inoculum, a 1-ml suspension of 5 ϫ 10 5 CFU S. aureus was applied directly on the mesh using a sterile syringe. The incision was closed using polyglactin 910 (Vicryl) suture and reinforced with skin staples. Topical bitter orange (ARC Laboratories, Atlanta, GA) was applied over the closure to dissuade wound disruption. All animals received bupranorphine (0.03 mg/kg of body weight) immediately after surgery and every 12 h thereafter for the next 48 h.
The assessment of the wound healing process was performed by a clinician and a veterinarian and was based on the wound's appearance, in accordance with the standard clinical and veterinary criteria. Normal healing constitutes airtight approximation of the wound edges without drainage, induration, tenderness (assessed by animal aversion to gentle palpation), erythema, and warmth to touch. The presence of any of these criteria in combination with separation of the wound edges would constitute impaired healing or nonhealing of the wound. Nonhealing wounds have a progressive course with increasing purulence, sepsis, and death. Rats with complex wound infection were treated according to NIH criteria and were euthanized (12) .
Mesh explantation was performed on day 7 after implantation. General anesthesia was induced with isoflurane and the animals were euthanized by intracardiac pentobarbital injection. The skin around the original incision was prepared in the same fashion described above and opened sharply and widely to allow full exposure of the graft implant. The entire abdominal wall, including the mesh interface was excised in en-bloc fashion. For quantitative bacterial culture analysis, the mesh was carefully separated from the muscle, agitated, and washed five times with sterile phosphate buffer solution. These washings were serially diluted up to the final concentration of 10
Ϫ8
, and each dilution was plated on tryptic soy agar and allowed to incubate overnight at 37°C. Bacterial colonies were then counted.
Statistical analysis. Data are presented as means Ϯ SDs. One-way analysis of variance (ANOVA) was performed for colony counts from the broth supernatant and wash to compare the samples with different initial enzyme concentrations. The null hypothesis was that the means are not significantly different. Tukey's test was used to compare different samples in the event that the ANOVA null hypothesis was not true. Data were analyzed using Origin (version 8) data analysis and graphing software (OriginLab Corporation, MA). A P value of Ͻ0.05 was considered statistically significant.
RESULTS
Binding yield of lysostaphin. Binding yield was calculated on the basis of the amount of fluorescently labeled enzyme adsorbed on mesh and corresponded to the difference in fluorescence intensities of initial enzyme and the supernatant solutions as described above. Figure 1 shows the binding yield for Alexa Fluor-labeled lysostaphin on a 1-by 1-cm polypropylene mesh. The amount of adsorbed enzyme per unit BET surface area (g/cm 2 ) is plotted as a function of the initial enzyme concentration. On the basis of the above-described experimental conditions, 18 to 40% of the lysostaphin initially present in the solution remained bound to the mesh after treatment by Tween 20 solution. The degree of surface coverage on the mesh can be predicted from the binding yield of enzyme. Average dimensions of the lysostaphin molecule are 4.5 nm by 5.5 nm by 8.5 nm. The average surface area occupied by an adsorbed protein molecule, on the basis of the smallest dimensions, is 25.02 nm 2 . The maximum theoretical monolayer of lysostaphin adsorbed on a 1-by 1-cm piece of polypropylene mesh calculated using the above surface area per molecule and the BET specific surface area of the mesh (3.8 ϫ 10 16 nm 2 ) consisted of 1.5 ϫ 10 15 molecules. Thereafter, theoretical 50%, 100%, and 150% monolayer coatings of adsorbed lysostaphin were calculated at initial enzyme concentrations of 100, 250, and 500 g/ml, respectively. Typically, the amount of adsorbed enzyme on a surface increases sharply at a low initial enzyme concentration and reaches a plateau at higher concentrations, thereby approaching a certain limiting value for adsorption (20) . In our case, adsorption did not reach saturation even at the highest coating concentration of 0.5 mg/ml, suggesting the possibility of multilayer adsorption at higher concentrations.
Lysostaphin leaching. Enzyme leaching could be a potential problem in the case of noncovalent adsorption, as the functional protein may be replaced on the surface by more abundant nonfunctional ones in vivo. Also, the mesh is constructed of a monofilament lightweight large porous polypropylene with pores larger than 3 mm, which could result in initial confine- 
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ANTIMICROBIAL LYSOSTAPHIN-COATED HERNIA REPAIR MESHES 4381 ment of the enzyme followed by release in vivo (22) . In our study, lysostaphin leaching was assessed in the presence of 2% (wt/vol) BSA as a model for the most abundant protein in the abdominal fluid. Figure 2 shows the standard curve representing the rate of lysis for the standards with known enzyme concentration. From this standard curve, the unknown enzyme concentrations were determined and the amount of leached enzyme for each of the samples was plotted as a function of time. The samples designated on the basis of their initial lysostaphin concentrations of 10 g/ml, 25 g/ml, 50 g/ml, 100 g/ml, 250 g/ml, and 500 g/ml were L-10, L-25, L-50, L-100, L-250, and L-500, respectively. An overall 0.01 to 3% leaching of enzyme based on the initial coating concentration from all the studied samples was observed after 24 h of incubation in BSA (data not shown). Bacterial lysis was observed in all mesh samples, including those that leached very small amounts of lysostaphin at the different time points, suggesting that low concentrations of enzyme could be effective in inhibiting growth of cells. In vitro antimicrobial activity against S. aureus was evaluated for all of the above samples (L-10 through L-500) using turbidity assay and the colony-counting method. Turbidimetric antibacterial activity assay. Activity assay provides the most direct measure of an enzyme's functionality. Qualitative evaluation of lysostaphin activity was done by monitoring the cell lysis of an S. aureus cell suspension (21) . The degree of cell lysis is directly proportional to the decrease in OD 600 of the bacterial suspension. The decrease in optical density of the bacterial suspension was monitored, and the initial rates of lysis were compared for the samples with different enzyme coatings. Figure 3 shows the time courses of bacterial degradation for three polypropylene samples and the polyester sample along with the appropriate controls. The vials containing the cell suspension were continuously shaken in order to maintain constant contact with the meshes. Table 1 compares the specific enzyme activity of samples with different enzyme coating concentrations for all polypropylene samples and one polyester sample.
Leached enzyme activity assay. It is important to know whether the activity of coated meshes is due to immobilized or leached enzyme. A turbidity assay that compared the activity of the leached sample against the total activity of the enzyme-coated mesh at different time points (incubated in bovine serum albumin) was performed to calculate the fraction of activity contributed by lysostaphin leaching from the mesh surface into the cell suspension. Enzyme leaching during the first 5 h (which was the duration of the turbidity assay) never exceeded 1% (data not shown). However, extremely low concentrations of lysostaphin leaching from the mesh can cause significant lysis to its natural substrate, i.e., cell walls of S. aureus. Fractional analysis of enzyme activity was performed for the aliquots collected at different time intervals and compared against total mesh activity for different coating concentrations for 24 h in 2% BSA. It was found that the lytic activity for these samples is almost entirely due to enzyme leaching from the mesh and lysing on October 31, 2017 by guest http://aac.asm.org/ bacteria in the surrounding supernatant rather than adsorbed lysostaphin (data not shown).
In vitro characterization of polyester mesh. In vitro characterization of polyester mesh was performed using the same methods described above for the polypropylene mesh. Only one lysostaphin coating concentration of 100 g/ml was used in the case of polyester; the same coating concentration was further used in vivo. The polyester sample was designated L-100P. The amount of lysostaphin adsorbed on this polyester mesh sample was found to be 2.4 Ϯ 0.2 g/mg mesh, compared to 4.4 Ϯ 0.2 g/mg mesh for the corresponding polypropylene sample (L-100). However, since the polyester mesh is heavier than the polypropylene sample (13.2 and 6.9 mg per 1-by 1-cm 2 mesh piece, respectively), the amounts of lysostaphin loaded on were similar and corresponded to 32.2 Ϯ 2.7 and 30.6 Ϯ 1.7 mg per 1-by 1-cm 2 piece, respectively. This ensured that a similar lysostaphin dose was utilized in the in vivo study which employed samples L-100 and L-100P.
The L-100P polyester mesh sample showed considerably higher leaching (ϳ3% in 5 h) than the L-100 polypropylene sample (less than 1% leaching). Correspondingly, the L-100P polyester sample showed an almost 2-fold higher enzyme activity (6.97 Ϯ 0.3 units per ml) than the L-100 polypropylene sample (Table 1 and Fig. 3 ), confirming the hypothesis that most of antimicrobial activity comes from the leached enzyme. Comparing the bacterial log reduction for sample L-100P to the reductions for samples L-10, L-25, L-50, L-100, L-250, and L-500, no significant difference was observed (Table 2) .
Colony counting. Log reduction in bacteria is estimated as the logarithm of the ratio of the initial number of bacterial colonies to the average final number of surviving colonies after treatment. This has been used for both broth supernatant and wash counts. Table 2 shows the log reduction in colonies recovered from the broth supernatant and wash counts for all the different initial coating concentrations. Broth count is a model for activity against the bacteria present in the wound fluid, while the wash count models activity against colonized bacteria present on the surface of the mesh, as initial bacterial attachment plays an important role in infection. An averaged 1.6 Ϯ 0.4 log reduction in bacterial counts was observed in the case of broth supernatant recovered from all the lysostaphin-coated mesh samples after 24 h of incubation with bacteria. There was no significant difference between samples with different initial lysostaphin coating concentrations (P Ͼ 0.05; one-way ANOVA); however, the observed log reduction was significantly higher for all the lysostaphin-coated samples than uncoated mesh samples (P Ͻ 0.05; Tukey's test). Similarly, an average 1.8 Ϯ 0.4 log reduction in bacterial counts from the pooled wash count was observed for all the samples that were not significantly different from each other (P Ͼ 0.05; one-way ANOVA). In contrast, uncoated mesh samples showed hardly any antimicrobial activity and the bacteria thrived in their presence, as indicated by a comparable surviving bacterial count with plain control cells. Bacterial adherence to the mesh is a known precursor to prosthetic infection (1, 14) . Significantly fewer numbers of CFU were recovered from the wash counts for lysostaphin-coated samples than the uncoated samples (P Ͻ 0.05). It is thus evident from the observed data that lysostaphin-coated meshes are able to both efficiently kill bacteria in solution and possibly inhibit surface colonization of bacteria.
In vivo rat model trial. All 40 rats survived to the time point of mesh extraction at 7 days. Groups that did not have an S. aureus inoculum (groups A, C, E, G, and I) had sterile cultures at the time of extraction. None of the lysostaphin-treated controls had impaired healing. Two of four rats with polyester and no lysostaphin and one of four with polypropylene and no lysostaphin had wound complications. All of the rats receiving an S. aureus inoculum and no lysostaphin had positive mesh cultures at 7 days. Animals treated with L-50 and inoculated with 5 ϫ 10 5 CFU of S. aureus had positive mesh cultures. The L-100 group with a 5 ϫ 10 5 -CFU S. aureus inoculum (groups F and J) had negative cultures (Table 3) . 
DISCUSSION
Bacterial infection at the site of implanted medical devices presents a serious and ongoing problem in the biomedical arena. Mesh implantation has reduced the rate of recurrent hernia but has led to an increased rate of bacterial infections. The incidence is reported to be as high as 8% following repair of incisional hernias (15, 16, 17) . Although mesh-related infections occur relatively infrequently compared to other devicerelated infections, it can cause significant morbidity, resulting in non-wound healing, recurrent hernia, and need for reoperation and mesh excision. Considering that nearly 1 million inguinal and incisional hernia repairs are done every year, this is a real and significant medical issue.
In our current study, the in vitro antimicrobial susceptibility of S. aureus to lysostaphin-coated hernia repair meshes was evaluated, and the effect of different enzyme coating concentrations on antimicrobial activity was also studied. Lysostaphin is a glycylglycine endopeptidase isolated from Staphylococcus staphylolyticus which specifically cleaves pentaglycine cross bridges found in the staphylococcal peptidoglycan (27) . It kills S. aureus within minutes (MIC 90 , 0.001 to 0.064 g/ml) (23). The antimicrobial activity of the meshes is primarily due to the extremely low concentrations of lysostaphin leaching from the mesh surface into the supernatant. Interestingly, Shah et al. observed that the antimicrobial activity of lysostaphin coated on two different plastic surfaces, polystyrene (well plates) and fluorinated ethylene-propylene (FEP) polymer, a Teflon-like material used in Angiocath catheters, was primarily due to immobilized but not leached enzyme (28) . These authors used a methodology similar to that reported here. One possible explanation is the difference in materials used in our studies and the studies of Shah et al. (28) . Ultrapro, a lightweight polypropylene macroporous mesh (with a Monocryl weave) containing an absorbable component of poliglecaprone, is different in density, weave, porosity (3 mm), and relative hydrophobicity. It has more yarn-like properties with a higher specific surface area than flat surfaces, such as polystyrene well plates and the lumenal sides of catheters made up of FEP polymer. Therefore, larger amounts of lysostaphin can be adsorbed to and consequently leached from the polypropylene mesh, leading to an increased fraction of activity coming from the leached enzyme. These concentrations are slightly higher than its MIC, and enzyme release from the mesh into surrounding tissue or fluids can be expected to counter any initial elevated infection risk immediately postsurgery or postimplantation.
A 6-h postimplantation decisive period has been identified during which prevention of bacterial colonization mediated by adhesion is critical to the long-term success of an implant (19) . Concentrations of lysostaphin that leached from the mesh in the first 5 h of incubation in BSA varied from 0.0026 to 0.5 g/ml, depending upon the initial coating concentration of enzyme. This is followed by a sustained release of enzyme at the same concentration that could be effective against occurrence of a latent infection. Passive coatings that aim to reduce bacterial adhesion are not as effective as active coatings that are designed to allow release of antibacterial agents immediately following the implantation (19) . The antimicrobial activity of the lysostaphin-coated meshes suggests that such enzyme-releasing surfaces could be efficient at actively resisting bacterial adhesion and preventing subsequent colonization of the implant.
From the colony-counting data, the antimicrobial activity was not significantly concentration dependent in the range of 25 to 500 g/ml (samples L-25 to L-500), as all the six samples reduced bacterial titers to the same level. This agrees well with the previously reported data (28) . The previous investigators found that lysostaphin adsorbed onto two different plastic surfaces, i.e., polystyrene and FEP polymer, showed killing that was not concentration dependent, where all coating concentrations (0.1, 1, and 10 mg/ml) reduced the bacterial count to the same level. Bacterial adhesion after 24 h of incubation in a 10 7 -CFU/ml S. aureus suspension is greatly reduced by enzyme-coated meshes compared to uncoated sample.
The results of the in vivo study show that none of the controls had bacterial contamination at 7 days. Treatment with L-50 was insufficient to clear all of the bacterial inoculum, as evidenced by positive cultures in all rats in group D. Interestingly, when the treatment concentration was doubled to 100 g/ml (sample L-100), despite the presence of a foreign body, the entire bacterial load was cleared. Although the colony count data in the in vitro studies did not demonstrate a significant difference in the bactericidal activity of lysostaphin at different concentrations, the antibacterial efficacy of lysostaphin appears to be dose related in vivo. The dramatic antimicrobial activity in the group treated with 100 g/ml demonstrates the great potential for lysostaphin for preventing staphylococcus-related prosthesis infections in the clinical setting.
In conclusion, we characterized the antimicrobial activity of lysostaphin-coated hernia repair mesh against S. aureus at different coating concentrations. Our early in vivo trial did not show impaired wound healing in the lysostaphin-treated groups; furthermore, it shows that lysostaphin has significant promise in preventing prosthesis infection when it is used at a dose of 100 g/ml. Utilizing such an antibiotic-free approach, one can effectively control the release of enzyme locally in the area of implant infection, by using an appropriate coating concentration that would result in lower systemic toxicity and higher antibacterial efficacy. Further work is on the way to confirm our findings in the clinical arena. Surface coatings using antibacterial enzymes could be a groundbreaking addition to the field of hernia repair and other areas of surgery in which prosthetic materials, or even biological materials, are implanted.
